[HTML][HTML] Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma
D Hannani - Frontiers in immunology, 2015 - frontiersin.org
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
[PDF][PDF] Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma
D Hannani - Front. Immunol. 6: 349. doi: 10.3389/fimmu, 2015 - researchgate.net
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
[HTML][HTML] Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma.
D Hannani - Frontiers in Immunology, 2015 - europepmc.org
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
[PDF][PDF] Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
D Hannani - Frontiers in Immunology, 2015 - hal.science
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
[引用][C] Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
D Hannani - Frontiers in Immunology, 2015 - cir.nii.ac.jp
Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current
Dogma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Dogma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[引用][C] Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
D Hannani - Frontiers in immunology, 2015 - pubmed.ncbi.nlm.nih.gov
[HTML][HTML] Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
D Hannani - Frontiers in Immunology, 2015 - ncbi.nlm.nih.gov
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
[PDF][PDF] Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma
D Hannani - Front. Immunol. 6: 349. doi: 10.3389/fimmu, 2015 - Citeseer
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma.
D Hannani - Frontiers in Immunology, 2015 - europepmc.org
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
[PDF][PDF] Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma
D Hannani - Front. Immunol. 6: 349. doi: 10.3389/fimmu, 2015 - hal.science
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …